Discussing the trends in cell and gene therapeutics, with Joel Eichmann, CEO, Green Elephant, live at Phacilitate
Talking to us live from Phacilitate, which took place in Miami, Florida, in January, Green Elephant CEO Joel Eichmann discusses the origins of his company, a biotech startup providing plant-based plastic laboratory equipment, and how the industry could benefit from making the shift to more sustainable everyday practises.
Credit: Author supplied
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
November 7, 2014
0 min read
Many drug developers are going ‘full steam ahead’ with personalized medicine strategies. They would be wise to consider a more equitable business model for an essential partner in the process: the developer of the companion diagnostic.
May 7, 2025
5 min read
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
April 1, 2025
3 min read
Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”
April 1, 2025
9 min read
Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track.